Curaleaf Holdings (CURLF) Change in Taxes (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Change in Taxes of $12.7 million for Q4 2024, up 149.71% year-over-year from $5.1 million in Q1 2024, and up 183.25% quarter-over-quarter from $4.5 million in Q3 2024.
Curaleaf Holdings (CURLF) Change in Taxes (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Change in Taxes history runs 6 years deep, the most recent figure standing at $12.7 million for Q4 2024.
- In Q4 2024, Change in Taxes rose 149.71% year-over-year to $12.7 million; the TTM figure through Dec 2024 stood at $5.5 million (down 44.51% YoY), while the FY2024 annual figure was -$174.6 million, down 463.83% from the prior year.
- Change in Taxes for Q4 2024 stood at $12.7 million, up from $4.5 million in the prior quarter.
- The five-year high for Change in Taxes was $67.1 million in Q3 2021, with the low at -$57.7 million in Q2 2022.
- The 5-year median for Change in Taxes is $10.6 million (2020), against an average of $6.1 million.
- Peak annual rise in Change in Taxes reached 668.12% in 2021, while the deepest fall reached 666.45% in 2021.
- Curaleaf Holdings' Change in Taxes stood at $47.8 million in 2020, then plunged by 151.38% to -$24.5 million in 2021, then rose by 17.3% to -$20.3 million in 2022, then declined by 26.17% to -$25.6 million in 2023, then soared by 149.71% to $12.7 million in 2024.
- Business Quant data shows CURLF's Change in Taxes at $12.7 million in Q4 2024, $4.5 million in Q3 2024, and -$25.6 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -106.03 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 40.90 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -59.60 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12.73 Mn |
| Dec 31, 2024 | 12.73 Mn |
| Sep 30, 2024 | 4.50 Mn |
| Sep 30, 2024 | 4.50 Mn |
| Dec 31, 2023 | -25.61 Mn |
| Dec 31, 2023 | -25.61 Mn |
| Sep 30, 2023 | 13.88 Mn |
| Sep 30, 2023 | 13.88 Mn |
| Dec 31, 2022 | -20.30 Mn |
| Dec 31, 2022 | -20.30 Mn |
| Sep 30, 2022 | 41.94 Mn |
| Sep 30, 2022 | 41.94 Mn |
| Jun 30, 2022 | -57.68 Mn |
| Jun 30, 2022 | -57.68 Mn |
| Mar 31, 2022 | 43.86 Mn |
| Mar 31, 2022 | 43.86 Mn |
| Dec 31, 2021 | -24.54 Mn |
| Dec 31, 2021 | -24.54 Mn |
| Sep 30, 2021 | 67.15 Mn |
| Sep 30, 2021 | 67.15 Mn |